SMS Pharmaceuticals Ltd. (SMSPHARMA): SMS Pharmaceuticals Share Price rises 8.01% today to Rs 445.50
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
SMS Pharmaceuticals Share Price is in focus after SMS Pharmaceuticals Ltd. rose 8.01% to Rs 445.50 on 18 September 2026, compared with the previous close of Rs 412.45. The company’s market capitalisation stands at Rs 3,784.01 Cr, placing the latest move in a clearly measurable market context. The stock opened at Rs 417.05, matched its day low at Rs 417.05, and finished at the day high of Rs 445.50. Turnover stood at Rs 2.11 Cr. The supplied data confirms the price event, but it does not establish a company-specific catalyst.
For readers tracking SMS Pharmaceuticals Share Price Today, the important point is that the move happened within one trading session and was accompanied by a full-day close at the highest printed price of the day. That makes SMS Pharmaceuticals Stock News relevant for investors watching SMS Pharmaceuticals Share Price Live, SMS Pharmaceuticals Share Price Update and SMS Pharmaceuticals Latest News on Univest. The verified numbers also allow a basic view of valuation and sector positioning, which matters more than speculation when no catalyst is supplied.
SMS Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 445.5 |
| Previous Close | Rs 412.45 |
| Today's Move | Rs 33.05 (+8.01%) |
| Open | Rs 417.05 |
| High | Rs 445.5 |
| Low | Rs 417.05 |
| Turnover | Rs 2.11 crore |
| Market Capitalisation | Rs 3,784.01 crore |
| Market Cap Category | Small Cap |
SMS Pharmaceuticals Ltd. (SMSPHARMA) rose to Rs 445.5 from the previous close of Rs 412.45, a move of Rs 33.05 or 8.01%. The stock opened at Rs 417.05, reached a high of Rs 445.5, recorded a low of Rs 417.05.
SMS Pharmaceuticals Share Price Today reflects a same-day gain of Rs 33.05, or 8.01%, with the stock ending at Rs 445.50 versus a previous close of Rs 412.45. The session range was tight on the downside because the day low and open were both Rs 417.05, while the day high and final price were both Rs 445.50. In simple market terms, the day’s print shows a clear share price rise, and SMS Pharmaceuticals stock news is being followed for the size of the move rather than for any unverified reason.
Univest tracks such moves as part of broader Stock Market Today and Share Market Today coverage, where the same-day change and turnover are the first verified facts to note. In this case, SMS Pharmaceuticals Share Price gained without any stated company event, so the move should be treated as an observed price action event, not as a explained corporate development. For searchers looking up SMS Pharmaceuticals Share Price Today, SMS Pharmaceuticals Stock Gaining Today or SMS Pharmaceuticals Stock Performance, these are the core numbers that define the session.
SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,784.01 crore |
| P/E Ratio | 42.67x |
| P/B Ratio | 4.68x |
| ROE | 11.99% |
| ROCE | 12.97% |
| EPS | Rs 9.67 |
| Book Value Per Share | Rs 88.19 |
| Dividend Yield | 0.1% |
SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 42.67x, P/B 4.68x, ROE 11.99%, ROCE 12.97%. These figures provide context only and are not a buy or sell signal.
SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 3784.01 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.67x, P/B at 4.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.99% and ROCE of 12.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 9.67, book value per share of Rs 88.19, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.67x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 4.68x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 11.99% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 12.97% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 3,784.01 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.67x, which is above the benchmark median of 32.69x, a difference of +30.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 11.99%, which is above the benchmark median of 11.78%, a difference of +1.78%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 12.97%, which is below the benchmark median of 13.65%, a difference of -4.98%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.67x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.99% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 12.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 3,784.01 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching SMS Pharmaceuticals
- SMS Pharmaceuticals Share Price rose 8.01% today to Rs 445.50, above the previous close of Rs 412.45.
- The stock closed at the day high of Rs 445.50 after opening at Rs 417.05.
- Market capitalisation stands at Rs 3,784.01 Cr, which places the company above the industry median benchmark.
- P/E is 42.67, P/B is 4.68, ROE is 11.99% and ROCE is 12.97%.
- Turnover for the session was Rs 2.11 Cr, adding one more verified data point for SMS Pharmaceuticals Share Price Today.
About SMS Pharmaceuticals
SMS Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break down revenue segments, product lines or geographic mix, so the most accurate company overview is the one directly supported by the records: it is a listed pharmaceutical business with valuation, profitability and market-cap data available for public review. That keeps SMS Pharmaceuticals Company News focused on what can be verified rather than on broad assumptions.
For readers following SMS Pharmaceuticals Share Price or SMS Pharmaceuticals News Today, the company is best understood through its listed-market profile: current price, market capitalisation, P/E Ratio, P/B Ratio, ROE, ROCE, EPS, book value and dividend yield. Univest uses those fields to connect price action with fundamental analysis, so the stock can be tracked in one place without mixing facts with speculation.
Track SMS Pharmaceuticals Share Price on Univest
Use SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
The same page also helps users compare SMS Pharmaceuticals Share Price Update data with peers, sector metrics and company fundamentals. For anyone monitoring SMS Pharmaceuticals Latest News or SMS Pharmaceuticals Share Price Live, Univest keeps the price event and the research context together in a format built for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did SMS Pharmaceuticals Share Price rise today?
Ans. The supplied data confirms an 8.01% rise to Rs 445.50, but it does not establish a company-specific catalyst. The session also ended at the day high, which is the verified market fact to note.
What is SMS Pharmaceuticals Share Price Today?
Ans. SMS Pharmaceuticals Share Price Today is Rs 445.50. It moved up from the previous close of Rs 412.45 and gained Rs 33.05 during the session, making it a clear same-day price rise.
What is the market capitalisation of SMS Pharmaceuticals Ltd.?
Ans. SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 3,784.01 Cr. Market cap indicates company size, while the stock’s valuation still needs to be read through P/E, P/B and return ratios.
How does SMS Pharmaceuticals compare on valuation?
Ans. SMS Pharmaceuticals has a P/E of 42.67 and P/B of 4.68. Both are above the industry medians of 32.69 and 3.10, so the stock trades above the benchmark median. The company trades at a P/E ratio of 42.67x.
What do ROE and ROCE show for SMS Pharmaceuticals?
Ans. ROE is 11.99% and ROCE is 12.97%. ROE is slightly above the industry median, while ROCE is slightly below it, giving a mixed but measurable profitability picture for the company.
How does SMS Pharmaceuticals compare with peers?
Ans. The company’s P/E is above Cipla and Zydus Lifesciences, but below Divi’s Laboratories and Torrent Pharmaceuticals. Its market cap is far smaller than Sun Pharmaceutical Industries and other large listed peers.
Where can I track SMS Pharmaceuticals Share Price on Univest?
Ans. You can track SMS Pharmaceuticals Share Price on Univest through the company’s stock page, where live price updates, valuation ratios, sector context and related stock news are brought together for quick review.
